Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03611309 · ClinicalTrials.gov registry record · NA
Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members
A NA study of Gastrointestinal Cancer, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 379
- Enrollment target
- 5
- Study locations
NCT03611309: Completed NA study of Gastrointestinal Cancer, sponsored by Stanford University.
NCT03611309 is a NA study of Gastrointestinal Cancer that has completed, run by Stanford University. The registered enrollment target is 379 participants, above the 222-participant average among 49 other Gastrointestinal Cancer trials with a reported enrollment target (71% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03611309, a NA study of Gastrointestinal Cancer, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 379 participants
- Enrollment target
- 5
- Study locations
Study Summary
The study goal is to compare surgeon-palliative care team co-management, versus surgeon alone management, of patients and family members preparing for major upper gastrointestinal cancer surgery. The study also aims to explore, using qualitative methods, the impact of surgeon-palliative care team co-management versus surgeon alone management on the perioperative care experience for patients, family members, surgeons, and palliative care clinicians.
Primary Outcome
Patient quality of life will be measured by the Functional Assessment of Chronic Illness Therapy Palliative care subscale (FACIT-PAL). FACIT-PAL is a compilation of general questions divided into four primary QOL domains: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, and Functional Well-Being. FACIT-PAL has 46 item self report measure. The range is from 0-184 for the FACIT-PAL. A higher score is a better outcome.
Conditions Studied
Interventions
- OTHER Surgeon-palliative care team co management
- OTHER Surgeon team alone management
Study Locations (5)
California
- Stanford University - Stanford
Maryland
- Johns Hopkins Hostpital - Baltimore
Massachusetts
- Dana Farber/ Brigham - Boston
New Mexico
- University of New Mexico - Albuquerque
Ohio
- Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2018-09-25 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
What the finished NCT03611309 record still lists
NCT03611309 is an interventional study that assigns participants to a tested intervention. The registered 379 participants enrollment target is mid-sized for trials with a published cap, above the 222-participant average among 49 other Gastrointestinal Cancer trials with a reported enrollment target (71% higher).
The record links to 1 condition, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Surgeon-palliative care team co management is the first listed.
NCT03611309 lists 5 locations in 5 states (California, Maryland, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT03611309 about?
NCT03611309 is a clinical study titled "Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members". The study goal is to compare surgeon-palliative care team co-management, versus surgeon alone management, of patients and family members preparing for major upper gastrointestinal cancer surgery. The study also aims to explore, using qualitative methods, the impact of surgeon-palliative care team co...
What is the current status of trial NCT03611309?
This trial is currently completed. It is a NA study. The enrollment target is 379 participants. The study started on 2018-09-25. Estimated completion is 2022-08-31.
What conditions does trial NCT03611309 study?
This clinical trial studies the following conditions: Gastrointestinal Cancer.
What interventions are being tested in trial NCT03611309?
The interventions under investigation include: Surgeon-palliative care team co management (OTHER), Surgeon team alone management (OTHER).
Who is sponsoring clinical trial NCT03611309?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03611309 being conducted?
This trial has 5 study locations across California, Maryland, Massachusetts, New Mexico, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03611309's enrollment target sits among peer trials
379 8th of 49 higher than 42 of 49 other Gastrointestinal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastrointestinal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Improving Comprehensive Care of Cancer Patients
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
RECRUITING · NA
-
REmote Symptom COllection to improVE postopeRative Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI